- Published: Tuesday, 28 January 2014 13:35
- Written by Administrator
Miami, FL and New York, NY, September 18, 2013 – Noven Pharmaceuticals, Inc., today announced the publication of results from its two Phase 3 clinical studies in Menopause, the peer-reviewed, scientific journal of The North American Menopause Society. Brisdelle™, paroxetine capsules, 7.5 mg/day, was approved by the United States Food and Drug Administration in June 2013, for the treatment of moderate to severe vasomotor symptoms (VMS) associated with menopause, commonly referred to as hot flashes and night sweats.
Listen to our expert Amy Stein by clicking this link HERE.
This video was shot by famed photographer, Robert Fogarty, with a heart-warming way of reaching out to share a message.
See the WISH page now at www.yourvoiceyourwish.com
We ask women..D0 you have a wish? Do you
A study in the Journal of the American Medical Association (JAMA, April 6,2011)) sheds new light on taking estrogen. Here is what it means to you.
Estrogen versus Estrogen and Progesterone and Uterine Cancer
Like all medications, estrogen is a powerful hormone with benefits and risks that have to be weighed and personalized for each woman. Forty years ago estrogen was so popular and considered so beneficial that almost all women were encouraged to take it from the time of menopause until death. Unfortunately, it was found that estrogen alone can cause cancer of the uterus. Women who have had a hysterectomy and had their uterus removed don’t have this problem.
Then researchers discovered that women who take daily estrogen combined with progesterone for at least 10 days of the month did not get uterine cancer. There were some risks of blood clots and strokes, but overall it was believed that estrogen plus progesterone protected the uterus from uterine cancer and estrogen helped to prevent heart disease. The heart disease part of this changed with more research.
Over the course of a woman’s lifetime, approximately 1 in 8 women will be diagnosed with breast cancer. Most women are concerned about their personal risk for developing cancer and what they can do themselves to reduce their chances of getting the disease.
For the 20 million women who suffer from painful intercourse: the first book to address the multiple causes and the available treatments. Painful sex, estimated to affect millions of women, is a condition that causes embarrassment and silence—often going undiscussed or misdiagnosed; as many as 40 percent of women who suffer from it won’t seek medical care. And most medical professionals are still in the dark when it comes to women’s sexual pain. Now, three leading experts tackle the stereotypes, myths, and realities of sexual pain in this easy-to-understand, accessible guide that will help you get the help you need and deserve. Drs. Andrew Goldstein, medical director of www.ourgyn.com. Caroline Pukall, and Irwin Goldstein offer answers to your most pressing questions, as well as: Up-to-date information on the more than 20 causes of dyspareunia How to choose the right doctor—and how to interpret your doctor’s lingo Valuable tips for understanding dyspareunia, and what can be done about it Why physical therapy is recommended for nearly every condition that contributes to sexual pain How to rebuild sexual intimacy once the pain is gone. Featuring ground-breaking research and stories from women who’ve also suffered—and recovered—When Sex Hurts provides all of the tools you need to stop hurting and start healing. You can discuss at our forums, blog about you problems and help form a support community.